Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway
Chemical Biology & Drug Design · 2026-03 · 107 (3)
DOI: 10.1111/cbdd.70275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 08.03.2026. Verfasst von Kongbo Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Respiratory Medicine, Nanyang Central Hospital (Nanyang Maternal and Child Health Care Hospital), Nanyang, China. Hauptthemen laut MEDLINE: Quinazolines, NF-kappa B, Asthma, Indole Alkaloids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Pediatric asthma is a common chronic condition with several pathological features, including airway inflammation, remodeling, and oxidative stress. Rutaecarpine (RUT), a bioactive alkaloid, exhibits therapeutic efficacy against various allergic diseases. However, its roles in asthma and the underlying molecular mechanisms remain elusive. In this study, we established an ovalbumin (OVA)‐induced mouse model of asthma. The results showed that compared with the OVA‐challenged group, treatment with RUT (10 and 20 mg/kg) reduced lung tissue inflammatory scores by 37.5% and 50.0%, respectively. Additionally, RUT suppressed the production of interleukin (IL)‐4, IL‐5, and IL‐13, and decreased the counts of total cells, eosinophils, macrophages, neutrophils, and lymphocytes in bronchoalveolar lavage fluid. Regarding airway remodeling, RUT downregulated the mRNA and protein expression of α‐smooth muscle actin and type I collagen. Furthermore, periodic acid‐Schiff staining showed that RUT ameliorated OVA‐induced mucus hypersecretion. RUT treatment also exhibited a protective effect on OVA‐induced oxidative damage in lung tissues. Mechanistically, RUT suppressed OVA‐induced activation of the nuclear factor‐kappa B (NF‐κB) pathway. Collectively, RUT attenuated inflammation, airway remodeling, and oxidative stress in OVA‐induced asthmatic mice by inhibiting the NF‐κB pathway, highlighting its potential as an adjunct therapy for pediatric asthma and providing a theoretical basis for future clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Respiratory Medicine, Nanyang Central Hospital (Nanyang Maternal and Child Health Care Hospital), Nanyang, China.
- Department of Pediatrics, Chun'an First People's Hospital, Hangzhou, China.
ORCID-Profile: Junwei Chen
Zitieren
APA
Chen, K., & Chen, J. (2026). Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway. Chemical Biology & Drug Design, 107(3). https://doi.org/10.1111/cbdd.70275
Vancouver
Chen K, Chen J. Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway. Chemical Biology & Drug Design. 2026;107(3). doi:10.1111/cbdd.70275
BibTeX
@article{Chen2026,
author = {Chen, Kongbo and Chen, Junwei},
title = {Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {107},
number = {3},
doi = {10.1111/cbdd.70275}
}
EUVIMED